Compound Detail
CHEMBL1950289
TANZISERTIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1
Basic Information
| ChEMBL ID | CHEMBL1950289 |
| Name | TANZISERTIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | IBGLGMOPHJQDJB-IHRRRGAJSA-N |
17
Targets
51
Activities
3
Assay Types
22
PK Parameters
20
Publications
5
Known Names
1
Indications
3
Mechanisms
Molecular Properties
448.4
MW (Da)
3.66
ALogP
8
HBA
3
HBD
97.1
PSA (Ų)
0.55
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| c-Jun N-terminal kinase 1 inhibitor | INHIBITOR | Mitogen-activated protein kinase 8 | ✓ | ✓ |
| c-Jun N-terminal kinase 2 inhibitor | INHIBITOR | Mitogen-activated protein kinase 9 | ✓ | ✓ |
| c-Jun N-terminal kinase 3 inhibitor | INHIBITOR | Mitogen-activated protein kinase 10 | ✓ | ✓ |
Indications
Idiopathic Pulmonary Fibrosis
Activity Summary
IC50 36 meas. best 8.3
Kd 13 meas. best 9.0
Ki 2 meas. best 8.21
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Mitogen-activated protein kinase 10 CHEMBL2637 | Kd | 9.0 | 9.0 | 1.0 | 1 |
| Mitogen-activated protein kinase 9 CHEMBL4179 | Kd | 8.7 | 8.7 | 2.0 | 1 |
| Mitogen-activated protein kinase 9 CHEMBL4179 | IC50 | 8.3 | 7.5538 | 5.0 | 8 |
| Mitogen-activated protein kinase 10 CHEMBL2637 | IC50 | 8.22 | 7.4529 | 6.0 | 7 |
| Mitogen-activated protein kinase 9 CHEMBL4179 | Ki | 8.21 | 8.21 | 6.2 | 1 |
| Mitogen-activated protein kinase 8 CHEMBL2276 | Kd | 7.77 | 7.77 | 17.0 | 1 |
| Mitogen-activated protein kinase 8 CHEMBL2276 | Ki | 7.36 | 7.36 | 44.0 | 1 |
| Mitogen-activated protein kinase 8 CHEMBL2276 | IC50 | 7.21 | 6.7263 | 61.0 | 8 |
| Cyclin-G-associated kinase CHEMBL4355 | Kd | 6.81 | 6.81 | 156.0 | 1 |
| c-Jun N-terminal kinase, JNK CHEMBL2096667 | IC50 | 6.7 | 6.2333 | 200.0 | 3 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 6.42 | 6.42 | 380.0 | 2 |
| Mitogen-activated protein kinase 3 CHEMBL3385 | IC50 | 6.32 | 6.32 | 480.0 | 3 |
| Mitogen-activated protein kinase 14 CHEMBL260 | Kd | 6.14 | 6.14 | 729.0 | 1 |
| MAP kinase-activated protein kinase 2 CHEMBL2208 | Kd | 6.03 | 6.03 | 934.0 | 1 |
| Mitogen-activated protein kinase 8 CHEMBL1795174 | IC50 | 5.95 | 5.95 | 1120.0 | 1 |
| Mitogen-activated protein kinase 1 CHEMBL4040 | Kd | 5.91 | 5.91 | 1233.0 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 CHEMBL1163101 | Kd | 5.87 | 5.87 | 1356.0 | 1 |
| c-Jun N-terminal kinase CHEMBL4888451 | IC50 | 5.85 | 5.51 | 1400.0 | 2 |
| LIM domain kinase 2 CHEMBL5932 | Kd | 5.74 | 5.74 | 1840.0 | 1 |
| LIM domain kinase 1 CHEMBL3836 | Kd | 5.66 | 5.66 | 2173.0 | 1 |
| Myosin light chain kinase, smooth muscle CHEMBL2428 | Kd | 5.58 | 5.58 | 2625.0 | 1 |
| Serine/threonine-protein kinase SIK3 CHEMBL6149 | Kd | 5.53 | 5.53 | 2981.0 | 1 |
| Mitogen-activated protein kinase 14 CHEMBL260 | IC50 | 5.47 | 5.47 | 3400.0 | 2 |
| Mitogen-activated protein kinase 3 CHEMBL3385 | Kd | 5.43 | 5.43 | 3692.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1390.19 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 852.05 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 4932.95 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 5829.85 | ng.hr.mL-1 | Macaca fascicularis |
| AUC | 38566.7 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 44845.0 | ng.hr.mL-1 | Macaca fascicularis |
| CL | 39.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 3.4 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 2.9 | mL.min-1.kg-1 | Macaca fascicularis |
| Cmax | 700.0 | nM | Rattus norvegicus |
| Cmax | 7200.0 | nM | Canis lupus familiaris |
| Cmax | 11000.0 | nM | Macaca fascicularis |
| F | 30.0 | % | Rattus norvegicus |
| F | 30.0 | % | Rattus norvegicus |
| F | 27.0 | % | Canis lupus familiaris |
| F | 77.0 | % | Macaca fascicularis |
| MRT | 0.7 | hr | Rattus norvegicus |
| MRT | 7.3 | hr | Canis lupus familiaris |
| MRT | 10.0 | hr | Macaca fascicularis |
| Tmax | 1.5 | hr | Rattus norvegicus |
| Tmax | 2.5 | hr | Canis lupus familiaris |
| Tmax | 1.3 | hr | Macaca fascicularis |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5465560 | Tyrosine-protein kinase ABL1 | 15 |
| 22244937 | 10.1016/j.bmcl.2011.12.027 | Rattus norvegicus | 13 |
| - | 10.6019/CHEMBL5465560 | Epidermal growth factor receptor | 13 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL4689842 | U2OS | 10 |
| - | 10.6019/CHEMBL5465560 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 9 |
| 22244937 | 10.1016/j.bmcl.2011.12.027 | Cynomolgus monkey | 8 |
| - | 10.6019/CHEMBL5465560 | Mast/stem cell growth factor receptor Kit | 8 |
| 22244937 | 10.1016/j.bmcl.2011.12.027 | Canis familiaris | 8 |
| - | 10.6019/CHEMBL5465560 | Receptor-type tyrosine-protein kinase FLT3 | 7 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| 22244937 | 10.1016/j.bmcl.2011.12.027 | Mus musculus | 5 |
| - | 10.6019/CHEMBL5465560 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 3 |
| - | 10.6019/CHEMBL5465560 | Unchecked | 3 |
| 22244937 | 10.1016/j.bmcl.2011.12.027 | No relevant target | 3 |
| 22244937 | 10.1016/j.bmcl.2011.12.027 | c-Jun N-terminal kinase, JNK | 3 |
Data from ChEMBL 36 via Core Engine